Details of the Drug
- Generic Name:
- Drug Type:
- Kinase inhibitor
- How the Drug is Given:
Indications and Usage
Rezurock™ is approved for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
Side effects needing medical attention
The most common adverse reactions, including laboratory abnormalities, were infections, decreased muscle strength (asthenia), nausea, diarrhea, difficult or labored breathing (dyspnea), cough, edema, hemorrhage, abdominal pain, musculoskeletal pain, headache, phosphate decreased, gamma glutamyl transferase increased, lymphocytes decreased, and hypertension.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.